Loading insider details...
Beta
Latest Form 4 (Jul 14, 2026): Grant/Award of 22,426 SERA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 14, 2026 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 22,426 | n/a |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 38,817 | n/a |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 174,068 | n/a |
| Dec 5, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 292 | $890.60 |
| Nov 6, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 221 | $671.84 |
| Oct 6, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 227 | $717.32 |
| Oct 3, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 225,000 | n/a |
| Sep 5, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 222 | $743.70 |
| Aug 5, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 225 | $562.50 |
| Jul 8, 2025 | SERA PROGNOSTICS, INC. (SERA) | Sale | 234 | $552.24 |